CardiologyDr. Biswarup PurkayasthaCoronary Artery Disease

Consultant - Heart & Lung Transplant and Vascular Surgery, Artemis Hospitals, Gurgaon

Part 8 of 12 in Diagnosis & Management of Coronary Artery Disease

Stenting Versus Bypass: Matching the Procedure to the Patient

November 30, 2025

Beyond left main disease specifically, Dr. Biswarup Purkayastha offered general practitioners a working framework for the broader stenting-versus-bypass decision, built around durability rather than procedural convenience. A coronary stent, in his description, is a time-limited stopgap; while newer stents are marketed as lasting a patient's lifetime, more than ten years of reliable stent performance remains, in his words, a rarity. A well-performed coronary artery bypass graft, by contrast, offers disease-free survival typically in excess of ten years, and often fifteen to twenty.

The rule for younger patients

Purkayastha's summary rule is straightforward: if a patient has more than ten years of life expectancy ahead of them, they should generally receive a bypass rather than a stent, because a stent's limited lifespan means a younger patient is likely to need a second intervention later. Stenting still has a role in this group as a stabilizing bridge, buying time for a heart to recover function before a planned surgical procedure.

When stenting is the right call

Purkayastha listed the criteria that favor stenting: severe comorbidity, advanced age, frailty, reduced life expectancy, restricted mobility, a SYNTAX score below 22, and anatomy where a complete surgical revascularization is unlikely to succeed, for example because of poor-quality vein or artery conduits, a leg condition that rules out vein harvesting, or a chest wall abnormality that prevents harvesting the internal mammary artery.

When bypass is the right call

Conversely, the criteria favoring bypass are diabetes, reduced ejection fraction, left main coronary disease, complex multivessel disease with a high SYNTAX score, and any pathology involving the ascending aorta. Purkayastha's framing throughout was that PCI offers a quick, easy fix with a fast recovery and reasonable results in the first month, but bypass surgery is the option to choose when durability, measured in years added to a patient's life, is the actual clinical goal.

This guide is based on a live Jivo Masterclass — Dr. Biswarup Purkayastha taught doctors across Africa on November 30, 2025.

FROM THE LIVE Q&A

DR

Dr. Hiwot (Ethiopia, relayed by moderator)

A 70-year-old diabetic patient with end-stage renal disease, on hemodialysis for three and a half years, on aspirin and atorvastatin, is admitted with intermittent chest pain and a diagnosis of NSTEMI. What should be the next steps?

BP

Dr. Biswarup Purkayastha

Start with single antiplatelet therapy, aspirin, and unfractionated heparin rather than low molecular weight heparin, which recirculates in patients with compromised renal clearance. Dose the heparin roughly three times a day for about two weeks to get him through the acute crisis. Once his symptoms settle and he has had his dialysis, plan a coronary angiogram to decide between stenting and bypass. In a frail, elderly diabetic dialysis patient like this, stenting is usually the better option: it buys time with a much shorter recovery than an operation he may not tolerate well.

See all 10 questions from this masterclass →

Book a Consultation with Dr. Biswarup Purkayastha

Book on WhatsApp

Or message us on WhatsApp: +91 98182 98669

Frequently Asked Questions

Can a coronary spasm affect or cause a pectoralis muscle spasm?

No. A pectoralis muscle spasm is aggravated by a localized range-of-motion test, reaching an arm behind the back, for example, while true angina is unaffected by arm or shoulder movement. The two are mechanistically unrelated: manage the muscle spasm with non-steroidal anti-inflammatory drugs and treat a genuine coronary spasm as coronary disease.

What are the alternatives to a frozen elephant trunk (FET) procedure for aortic dissection?

If a frozen elephant trunk has not been done, the alternative is EVAR, endovascular aortic repair, sealing off the re-entry tear with a stent graft placed through the groin. In the thoracic aorta this is straightforward because there are no major branch vessels to route around. In the abdominal aorta, where the gastroepiploic, superior mesenteric, renal and inferior mesenteric arteries branch off, patient-specific imaging has to be sent to a stent graft manufacturer so they can build a graft with branches positioned at the right levels before it is deployed.

How should a general practitioner judge whether a coronary artery disease case needs a specialist referral, domestically or abroad, versus continued management at the primary care level?

Complexity is determined by the workup, not by symptoms alone. Watch the troponin and creatine kinase trend: if enzymes keep rising, or symptoms have not improved after 72 to 96 hours of conservative therapy, antiplatelet medication, or thrombolysis where that pathway was used, that is the signal to make a specialist referral so a senior physician can perform an angiogram and determine disease severity directly.

A 38-year-old man has had two years of intermittent chest pain, breathlessness and weakness, with two ECGs, two echocardiograms, a full blood panel and a 24-hour Holter all largely unremarkable, and no local access to CT coronary angiography. What is the next step?

One ECG showing borderline bradycardia, combined with a two-year history that has defeated standard testing, points toward right coronary artery disease, which is notoriously difficult to pick up outside direct angiography. Pending access to a coronary angiogram, start dual antiplatelet therapy, 75 mg of clopidogrel and 150 mg of aspirin daily, plus a statin at 40 mg daily to stabilize the plaque, and check cardiac enzymes at his next chest pain episode. A positive enzyme without an ECG change would classify him as unstable angina, since that diagnosis only requires a troponin derangement alongside chest pain, not an ECG change. A strong maternal family history of cardiac illness is relevant here even though he is young and does not smoke or drink.

What about the RFCL, risk factor weighted clinical likelihood, score? It placed this same patient at 10 percent.

RFCL is an old scoring system we do not use anymore; it produces more false negatives than anything useful. Score this patient with a EuroSCORE now, and a SYNTAX score once an angiogram is available.

How long does a coronary stent typically last compared to a bypass graft?

More than ten years of reliable stent performance remains rare, while a well-performed coronary artery bypass graft typically offers disease-free survival in excess of ten years, often fifteen to twenty.

What is the rule of thumb for choosing bypass over stenting based on a patient's age?

A patient with more than ten years of life expectancy ahead of them should generally receive a bypass rather than a stent, since a stent's limited lifespan makes a second intervention likely later.

What patient factors favor stenting over bypass surgery?

Severe comorbidity, advanced age, frailty, reduced life expectancy, restricted mobility, a SYNTAX score below 22, and anatomy where complete surgical revascularization is unlikely to succeed, such as poor-quality graft conduits.

What factors point toward bypass surgery rather than stenting?

Diabetes, reduced ejection fraction, left main coronary disease, complex multivessel disease with a high SYNTAX score, and any pathology involving the ascending aorta.

Need Expert Medical Guidance?

Connect with leading specialists through the Jivo Healthcare network for personalized advice.

Get Expert Opinion